USNA USANA Health Sciences, Inc. Common Stock
About USANA Health Sciences, Inc. Common Stock Company overview from Wikipedia
USANA Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 25 countries via a network of independent distributors.
Read more
USANA Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 25 countries via a network of independent distributors.
History
In 1992, immunologist and microbiologist Myron Wentz moved his diagnostic testing company, Gull Laboratories, from Salt Lake City to West Valley City, Utah, and spun it into USANA Health Services, a multilevel marketing manufacturer of supplements. Beginning in 1993, Dallin A. Larsen served as USANA's vice president of sales (and later as a consultant to USANA's president and special advisor to the board of directors) before founding the MLM beverage company Monavie in 2005. USANA's products are not available through retail channels, and can only be obtained through one of its independent distributors (referred to as "associates") or by direct order through the company.
On 20 February 2007, Barry Minkow, founder of the Fraud Discovery Institute, distributed a 500-page report to officials at the U.S. Securities and Exchange Commission (SEC), the Federal Bureau of Investigation (FBI), and the Internal Revenue Service (IRS) accusing USANA of operating an illegal pyramid scheme. The SEC conducted an investigation into USANA's business practices in March 2007 and found no evidence of wrongdoing, concluding its inquiry with no enforcement action recommended. Minkow acknowledged that he was shorting USANA's shares, hoping to profit from a drop in the stock price. In April 2007, a class action lawsuit was filed alleging that USANA's common stock had been artificially inflated. In August 2007, USANA was notified by the Securities and Exchange Commission (SEC) that its shares were subject to delisting from the NASDAQ due to its Form 10-Q, and was determined to be in compliance that October.
In January 2008, a shareholder suit was filed with allegations that USANA had misled investors about the sustainability of its growth and business model. The cases were dismissed, and the company was cleared by the U.S. Securities and Exchange Commission after an informal inquiry into the allegations, stating that it did "not intend to recommend any enforcement action by the Commission." Later that year, two Canadian USANA distributors were awarded $7 million in damages for their wrongful dismissal from the company. The firm had terminated their positions in 2003 because it believed the distributor had violated the companies' policies and procedures.
USANA filed suits against Minkow and his company claiming defamation and stock manipulation. USANA dropped the defamation suit and in March 2008 U.S. District Judge Tena Campbell threw out four of the five claims brought by USANA against Minkow ruling that USANA's claims violated California's anti-SLAPP law for suing Minkow for fair criticism and that USANA did not show a reasonable probability of winning on those claims. The remaining charge of stock manipulation was settled in July 2008, when USANA and Minkow reached an undisclosed settlement that included the removal of all USANA-related materials from the Fraud Discovery Institute website, a related Chinese website, and YouTube. Minkow also agreed to never trade in USANA's stock again.
In December 2010, USANA completed the application process to transfer its common stock listing from the NASDAQ National Market System, where it had traded since 1996, to the New York Stock Exchange. The transfer became official at the beginning of 2011. It received drug-establishment registration from the Food and Drug Administration to manufacture over-the-counter drugs later that year. In 2012, 91% of product sales were purchased by associates. The company acquired BabyCare Ltd., a China-based prenatal supplement company, in 2013 and announced plans to build a manufacturing facility in the country.
By 2018, USANA had reported record revenue due to growth in the Asia-Pacific region, though it recorded a 7% drop in net sales during its 2019 annual report. USANA has partnered with HealthCorps on health education for children and, in 2019, the USANA Foundation's Kids Eat program opened a facility to pack and distribute food for childhood hunger in the Utah area. It was also announced as the official nutritional partner of the Spartan Race endurance brand in the United States. Its sales for the first quarter of 2020 declined by 2.3 percent compared with 2019 numbers.
In February 2019, the Ministry of Commerce in China suspended operations of all multi-level marketing companies and participants to conduct a 100-day review of the country's health foods industry due to exaggerated advertising claims and questionable products in the unregulated sector. Chinese departments initiated "Hundred Days of Action" to clean up the health market, where 49 products from various companies were revoked, 54 food business licenses of various companies were revoked, 90 business licenses of various companies were revoked, and 465 counterfeit and fake dens were destroyed. 85 companies, including BabyCare Ltd., a USANA subsidiary, signed a declaration to self-discipline and regulate operations, with BabyCare speaking at an event hosted by the Chinese government.
Corporate affairs
Leadership
In 2007, USANA faced repeated controversy after members of its board of directors, medical advisory board and several of its executives made false statements regarding their qualifications, including education and licenses.
Founder Myron Wentz was the company's chief executive officer from 1992 until 2008, when his son, Dave Wentz, succeeded him after working in positions such as president, executive vice president, and senior vice president of strategic development. In 2015, USANA announced that the chief executive officer role would be divided between Wentz and Kevin Guest, with the former taking global operations and the latter, field development and sales. Guest was appointed the sole chief executive officer in November 2016.
Operations
USANA, a multilevel marketing company, sells its products primarily through non-employee distributors, known as sales "associates", as well as through the Internet. The firm's 2010 income disclosure statement defines "associates" as those who are actively building a business, acting as wholesale buyers, or are new distributors. The firm's 2009 SEC 10-K filing distinguishes between associates and preferred customers. Associates are independent distributors of USANA products and also purchase them for personal use. Preferred customers may purchase products at wholesale prices strictly for personal use and are not permitted to resell or distribute them. As of July 2011, the firm had 222,000 active Associates and 68,000 preferred customers. It manufactured 90% of its products at the Salt Lake City headquarters, which produced more than 22 million tablets each week.
Associates may be eligible to receive commissions based on their own product sales as well as through sales made by any new distributors they recruit. According to documentation from USANA corporate, 87 percent of associates fail to make enough from commissions to recover the cost of their qualifying purchases with 67 percent of all associates making no commission; the top 2.31 percent of associates earns 72.2 percent of the company's commissions. According to a 2011 article published by the Salt Lake City Tribune, the firm's FY09 income disclosure statement indicated that the average yearly income of the company's 165,710 associates, which includes those just starting, was $617, while the "top-of-the-pyramid distributors earn an average of $857,865 annually".
Sponsorships
USANA has been a paid sponsor of various athletic organizations. USANA offers an "Athlete Guarantee Program" to select sponsored athletes. The program permits selected participants to enter into an agreement with the company stipulating that, should an athlete enrolled in the program test positive for a banned substance (included in World Anti-Doping Agency regulations) as a result of taking USANA products, the company will compensate the athlete up to two times his or her current annual earnings up to $1 million USD.
In 2006, USANA signed a co-sponsorship agreement with the WTA Tour and extended it in 2011. The agreement provides athletes with nutritional supplements that are guaranteed to conform to the Tour's antidoping policy. As part of the agreement in 2011, USANA donated $1 to Children's Hunger Fund for every ace scored at a WTA tournament beginning at Wimbledon and continuing through the end of the season.
In 2003, USANA became the title sponsor of the USANA Amphitheatre, an outdoor amphitheatre based in West Valley City, Utah with a seating capacity of 20,000. In May 2012, United Concerts announced a continued naming rights partnership with USANA Health Sciences through March 2018.
In the lead-up to the 2020 Summer Olympics, USANA announced partnerships with USA Swimming and the USA Skateboarding National Team. It was the official multivitamin sponsor of USA Swimming and official nutritional supplement supplier of USA Skateboarding. The partnerships reportedly extended into multi-year agreements.
Products
USANA produces three product lines: USANA Nutritionals (Cellsentials, Optimizers, and Digestion/Detox nutritional supplements), USANA Diet & Energy (Reset meal replacement shakes, protein bars, and Rev3 energy drinks), and Sensé & Celavive personal care (skin care, skin treatment, and hair & body care products).
USANA Essentials were tested in 2011 by ConsumerLab.com in its Multivitamin and Multimineral Supplements Review of 38 leading multivitamin/multimineral products sold in the U.S. and Canada. The Essentials passed ConsumerLab's test, which included testing of selected index elements, their ability to disintegrate in solution per United States Pharmacopeia guidelines, lead contamination threshold set in California Proposition 65, and meeting U.S. Food and Drug Administration (FDA) labeling requirements.
As of 2019, its products are marketed in the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, the United Kingdom, the Caribbean, Puerto Rico, Philippines, France, China, Spain, Italy, Germany, Romania, Denmark, Colombia and Indonesia.
Reception
From 2004 to 2006, USANA was named on Forbes "200 Best Small Companies" list. In 2007, a Forbes article quoted industry experts and government officials who had raised questions about the cost of USANA's supplements and its business practices. Radio-Canada later aired an investigative report that examined the company's products, pricing and "misleading income claims" made to potential associates concerning revenue. It included hidden-camera footage of recruitment and other sessions, which found one group of associates appeared to violate the company's policies and distributor agreements. This contrasted with the Canadian legal requirements for multi-level marketing companies to provide clear, frequent and complete information about the revenue of the typical participant. In addition, the same group of associates were filmed making recommendations for using USANA products to treat illnesses including leukemia.
John Cloud, senior writer for Time Magazine, evaluated nutritional supplements in which he took a regimen of USANA pills, protein bars, powder drinks and psyllium fiber as recommended by the company's online evaluation. Cloud took a blood test before starting the products to measure levels of calcium, protein, sodium, cholesterol, glucose, and other substances, and was then tested again five months after starting the supplement regimen, which included 3,000 pills at a cost of $1,200. The follow-up test revealed a change in only two values; a 75% increase in vitamin D levels (attributed to the vitamin D3 supplement Cloud had been taking) and a 28 mg/dl increase in high-density lipoprotein, which could not be accounted for. Cloud also experienced a placebo response where that act of taking the supplements made him feel more vigorous despite no physiological reasons being present. This response also led to a 10-lb weight gain, as the belief that he was more vigorous led him to make poorer dietary decisions—a phenomenon referred to as the "licensing effect".
New Zealand government statistician for the Commerce Commission, Murray H. Smith, who served as an expert witness in every pyramid scheme case brought by the Commission preceding 10 years, opined in 2008 that very few USANA distributors are likely to become wealthy, and stated, "you can make a very strong argument that this could be a pyramid scheme." When asked by the National Business Review to review the firm's business structure and compensation plan, it was Smith's opinion, from a statistical not legal standpoint, that the firm demonstrated a number of characteristics commonly occurring in pyramid schemes including that most members recoup less than what they pay to participate; that those at the top of the structure are more likely to make more than those on the bottom of the structure; and that as the company grows it will become harder to recruit others. Smith also noted the company's significant turnover in distributors making it necessary to continually recruit.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
USNA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
USNA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
USNA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 0 0.0%
- Buy 0 0.0%
- Hold 3 50.0%
- Sell 1 16.7%
- Strong Sell 2 33.3%
12-Month Price Target
1 analysts · 2026-08-14Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-0.07 | $0.44 | -0.51% |
| March 31, 2026 | $0.61 | $0.45 | 0.16% |
| Dec. 31, 2025 | $0.60 | $0.42 | 0.18% |
| Sept. 30, 2025 | $-0.15 | $0.48 | -0.63% |
| June 30, 2025 | $0.74 | $0.55 | 0.19% |
| March 31, 2025 | $0.73 | $0.71 | 0.02% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| USNA | $355M | 33.5 | 8.3% | 1.2% | 2.0% | 78.3% |
| BRBR | $4.39B | 21.6 | 16.1% | 9.3% | -72.0% | 33.3% |
| HNST | $291M | -18.4 | -1.9% | -4.2% | -8.8% | 33.3% |
| NATR | $378M | 20.4 | 5.7% | 4.1% | 12.0% | 72.4% |
| NAGE | $507M | 31.8 | 29.9% | 13.4% | 24.7% | 64.3% |
| NUS | — | 3.0 | -14.3% | 10.8% | 22.0% | 69.5% |
| MED | $117M | -6.3 | -36.0% | -4.8% | -9.0% | 71.3% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 18
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $925M | $855M | $921M | $999M | $1.19B | $1.13B | $1.06B | $1.19B | $1.05B | $1.01B | $918M | $790M | |
| Cost of Revenue | $201M | $161M | $177M | $194M | $218M | $209M | $188M | $201M | $179M | $180M | $160M | $141M | |
| Gross Profit | $724M | $693M | $744M | $805M | $969M | $926M | $873M | $989M | $868M | $826M | $759M | $650M | |
| R&D Expense | $11M | $12M | $11M | $12M | $11M | $11M | $10M | $10M | $9M | $9M | $6M | $5M | |
| SG&A Expense | $337M | $263M | $257M | $262M | $279M | $261M | $268M | $275M | $265M | $234M | $209M | $185M | |
| Operating Expenses | $687M | $627M | $651M | $697M | $798M | $749M | $727M | $800M | $735M | $687M | $617M | $534M | |
| Operating Income | $37M | $66M | $93M | $108M | $170M | $176M | $146M | $188M | $133M | $139M | $142M | $116M | |
| Interest Expense | · | · | $262.0K | $192.0K | $57.0K | $507.0K | $66.0K | $36.0K | $46.0K | $444.0K | $15.0K | $129.0K | |
| Interest Income | $2M | $11M | $10M | $4M | $3M | $3M | $5M | $4M | $2M | $1M | $1M | $500.0K | |
| Other Non-op | $3M | $-1M | $7.0K | $-3M | $-2M | $-571.0K | $-335.0K | $-1M | $-3.0K | $-1M | $-174.0K | $-820.0K | |
| Pretax Income | $42M | $76M | $102M | $109M | $171M | $178M | $150M | $192M | $135M | $139M | $143M | $116M | |
| Income Tax | $30M | $34M | $39M | $39M | $54M | $53M | $50M | $65M | $72M | $39M | $48M | $39M | |
| Net Income | $11M | $42M | $64M | $69M | $117M | $125M | $101M | $126M | $63M | $100M | $95M | $77M | |
| EPS (Basic) | $0.58 | $2.20 | $3.31 | $3.60 | $5.78 | $5.89 | $4.44 | $5.24 | $2.57 | $4.14 | $3.72 | $2.90 | |
| EPS (Diluted) | $0.58 | $2.19 | $3.30 | $3.59 | $5.73 | $5.86 | $4.41 | $5.12 | $2.53 | $3.99 | $3.59 | $2.80 | |
| Shares (Basic) | 18,535,000 | 19,103,000 | 19,250,000 | 19,254,000 | 20,146,000 | 21,156,000 | 22,644,000 | 24,105,000 | 24,349,000 | 24,185,000 | 25,460,000 | 26,443,000 | |
| Shares (Diluted) | 18,574,000 | 19,162,000 | 19,345,000 | 19,310,000 | 20,343,000 | 21,256,000 | 22,818,000 | 24,642,000 | 24,708,000 | 25,047,000 | 26,355,000 | 27,377,000 | |
| EBITDA | $70M | $81M | $106M | $121M | $183M | $190M | $161M | $205M | $149M | $152M | $152M | $125M |
Balance Sheet 26
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $158M | $182M | $330M | $288M | $240M | $312M | $235M | $214M | $247M | $176M | $143M | $111M | |
| Receivables | $4M | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory | $103M | $70M | $61M | $67M | $98M | $90M | $69M | $82M | $63M | $65M | $66M | $45M | |
| Prepaid Expense | $23M | $28M | $26M | $29M | $27M | $23M | $26M | $33M | $30M | $37M | $35M | $35M | |
| Other Current Assets | $5M | $5M | $6M | $7M | $4M | $5M | $5M | $7M | $5M | $6M | $5M | $6M | |
| Current Assets | $288M | $279M | $418M | $384M | $365M | $425M | $329M | $392M | $340M | $278M | $244M | $191M | |
| PP&E (Net) | $94M | $95M | $100M | $98M | $102M | $100M | $95M | $92M | $103M | $101M | $88M | $71M | |
| PP&E (Gross) | · | · | $212M | $210M | $211M | $199M | $181M | $178M | $177M | $164M | $120M | $114M | |
| Accum. Depreciation | $135M | $130M | $129M | $125M | $122M | $116M | $105M | $96M | $86M | $76M | $71M | $64M | |
| Goodwill | $138M | $144M | $17M | $17M | $18M | $17M | $17M | $17M | $17M | $17M | $17M | $18M | |
| Intangibles | $133M | $152M | $30M | $32M | $30M | $31M | $30M | $32M | $35M | $34M | $38M | $41M | |
| Other Non-current Assets | $62M | $59M | $55M | $55M | $58M | $62M | $43M | $18M | $21M | $22M | $25M | $24M | |
| Total Assets | $743M | $748M | $633M | $597M | $578M | $641M | $517M | $554M | $519M | $471M | $423M | $351M | |
| Accounts Payable | $17M | $12M | $10M | $11M | $14M | $18M | $13M | $10M | $12M | $9M | $10M | $8M | |
| Accrued Liabilities | $10M | $14M | $10M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $129M | $140M | $119M | $144M | $161M | $168M | $136M | $149M | $141M | $138M | $131M | $109M | |
| Capital Leases | $12M | $10M | $5M | $8M | $10M | · | $17M | · | · | · | · | · | |
| Deferred Tax | $5M | $4M | $5M | $4M | $7M | $12M | $10M | $13M | $14M | $5M | $10M | $11M | |
| Other Non-current Liabilities | $23M | $18M | $12M | $14M | $14M | $19M | $19M | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $157M | $162M | $136M | · | · | · | · | · | · | · | · | · | |
| Common Stock | $18.0K | $19.0K | $19.0K | $19.0K | $19.0K | $21.0K | $22.0K | $24.0K | $24.0K | $24.0K | $25.0K | $13.0K | |
| Retained Earnings | $466M | $479M | $445M | $392M | $345M | $383M | $306M | $330M | $288M | $265M | $215M | $166M | |
| AOCI | $-16M | $-23M | $-14M | $-13M | $458.0K | $-4M | $-14M | $-10M | $-1M | $-12M | $-4M | $2M | |
| Stockholders' Equity | $533M | $532M | $497M | $434M | $395M | $442M | $352M | $391M | $363M | $325M | $281M | $230M | |
| Liabilities + Equity | $743M | $748M | $633M | $597M | $578M | $641M | $517M | $554M | $519M | $471M | $423M | $351M | |
| Shares Outstanding | 18,281,000 | 19,064,000 | 19,130,000 | 19,206,000 | 19,393,000 | 21,038,000 | 21,655,000 | 23,567,000 | 24,024,000 | 24,485,000 | 24,976,000 | 25,266,000 |
Cash Flow 16
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $33M | $15M | $13M | $13M | $13M | $14M | $15M | $17M | $16M | $13M | $10M | $9M | |
| Stock-based Comp | $14M | $15M | $15M | $13M | $14M | $14M | $16M | $15M | $15M | $17M | $11M | $10M | |
| Deferred Tax | $-7M | $-7M | $-3M | $-7M | $-3M | $-2M | $-4M | $607.0K | $19M | $-4M | $-3M | $-1M | |
| Amort. of Intangibles | $19M | $2M | $2M | $2M | $1M | $1M | $1M | $2M | $1M | $2M | $900.0K | $431.0K | |
| Restructuring | $6M | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-28M | $-3M | $-18M | $15M | $-20M | $10M | $-442.0K | $-7M | $10M | $11M | $-2M | $11M | |
| Operating Cash Flow | $22M | $61M | $71M | $104M | $121M | $160M | $127M | $152M | $124M | $137M | $111M | $105M | |
| CapEx | $14M | $10M | $14M | $10M | $13M | $15M | $17M | $11M | $13M | $33M | $24M | $20M | |
| Investing Cash Flow | $-10M | $-213M | $-12M | $-12M | $-14M | $-34M | $47M | $-69M | $-13M | $-32M | $-25M | $-16M | |
| Stock Repurchased | $28M | $9M | $12M | $25M | $178M | $57M | $150M | $105M | $50M | $65M | $61M | $139M | |
| Net Stock Activity | $-28M | $-9M | $-12M | $-25M | $-178M | $-57M | $-150M | $-105M | $-50M | $-65M | $-61M | $-139M | |
| Financing Cash Flow | $-41M | $10M | $-14M | $-30M | $-181M | $-59M | $-152M | $-105M | $-50M | $-65M | $-49M | $-113M | |
| Net Change in Cash | $-23M | $-149M | $42M | $48M | $-72M | $78M | $20M | $-33M | $72M | $32M | $32M | $-26M | |
| Taxes Paid | $37M | $40M | $42M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $9M | $51M | $56M | $94M | $108M | $145M | $110M | $141M | $111M | $104M | $88M | $85M | |
| Levered FCF | · | · | $56M | $93M | $108M | $145M | $110M | $141M | $111M | $104M | $88M | $85M |
Profitability 8
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.3% | 81.1% | 80.8% | 80.6% | 81.6% | 81.6% | 82.3% | 83.1% | 82.9% | 82.1% | 82.6% | 82.2% | |
| Operating Margin | 4.0% | 7.8% | 10.1% | 10.8% | 14.3% | 15.6% | 13.8% | 15.8% | 12.7% | 13.8% | 15.4% | 14.7% | |
| Net Margin | 1.2% | 4.9% | 6.9% | 6.9% | 9.8% | 11.0% | 9.5% | 10.6% | 6.0% | 9.9% | 10.3% | 9.7% | |
| Pretax Margin | 4.5% | 8.9% | 11.1% | 10.9% | 14.4% | 15.7% | 14.2% | 16.1% | 12.9% | 13.8% | 15.5% | 14.6% | |
| EBITDA Margin | 7.6% | 9.5% | 11.5% | 12.1% | 15.4% | 16.8% | 15.2% | 17.2% | 14.2% | 15.1% | 16.5% | 15.8% | |
| ROA | 1.4% | 6.1% | 10.4% | 11.8% | 19.1% | 21.5% | 18.8% | 23.5% | 12.6% | 22.4% | 24.5% | 21.3% | |
| ROE | 2.0% | 7.9% | 13.2% | 16.4% | 29.3% | 30.0% | 30.2% | 30.5% | 17.2% | 33.0% | 37.0% | 31.2% | |
| ROIC | 1.9% | 6.9% | 11.7% | 15.8% | 29.4% | 28.0% | 27.8% | 31.7% | 16.9% | 30.8% | 33.5% | 33.4% |
Liquidity & Solvency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 2.0 | 3.5 | 2.7 | 2.3 | 2.5 | 2.4 | 2.6 | 2.4 | 2.0 | 1.9 | 1.8 | |
| Quick Ratio | 1.2 | 1.3 | 2.8 | 2.0 | 1.5 | 1.9 | 1.7 | 1.4 | 1.8 | 1.3 | 1.1 | 1.0 | |
| Interest Coverage | · | · | 355.2 | 560.5 | 2985.8 | 348.1 | 2215.0 | 5232.0 | 2880.5 | 312.2 | 9444.1 | 900.0 |
Efficiency 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.2 | 1.5 | 1.7 | 1.9 | 2.0 | 2.0 | 2.2 | 2.1 | 2.3 | 2.4 | 2.2 | |
| Inventory Turnover | 2.3 | 2.5 | 2.7 | 2.3 | 2.3 | 2.2 | 2.5 | 2.8 | 2.8 | 2.8 | 2.9 | 3.0 |
Growth Rates 9
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 8.3% | -7.2% | -7.8% | -15.8% | 4.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -2.5% | -10.4% | -6.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -4.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -73.5% | -33.6% | -8.1% | -37.4% | -2.2% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -45.5% | -27.4% | -17.4% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -37.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -74.4% | -34.1% | -8.0% | -40.5% | -6.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -46.3% | -28.8% | -20.0% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -38.7% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM) 10
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $925M | $855M | $921M | $999M | $1.19B | $1.13B | $1.06B | $1.19B | $1.05B | $1.01B | $918M | $790M | |
| Net Income TTM | $11M | $42M | $64M | $69M | $117M | $125M | $101M | $126M | $63M | $100M | $95M | $77M | |
| Market Cap | $355M | $680M | $1.03B | $1.02B | $1.96B | $1.62B | $1.73B | $2.71B | $1.78B | $1.50B | $798M | $646M | |
| P/E | 33.5 | 16.3 | 16.2 | 14.8 | 17.7 | 13.2 | 18.1 | 22.5 | 29.3 | 15.3 | 17.8 | 18.3 | |
| P/S | 0.4 | 0.8 | 1.1 | 1.0 | 1.7 | 1.4 | 1.6 | 2.3 | 1.7 | 1.5 | 0.9 | 0.8 | |
| P/B | 0.7 | 1.3 | 2.1 | 2.4 | 5.0 | 3.7 | 4.9 | 6.9 | 4.9 | 4.6 | 2.8 | 2.8 | |
| P / Tangible Book | 1.4 | 2.9 | 2.3 | 2.7 | 5.7 | 4.1 | · | · | · | · | · | · | |
| P / Cash Flow | 15.9 | 11.2 | 14.5 | 9.8 | 16.2 | 10.1 | 13.7 | 17.8 | 14.4 | 10.9 | 7.2 | 6.1 | |
| P / FCF | 41.7 | 13.4 | 18.3 | 10.9 | 18.1 | 11.2 | 15.7 | 19.3 | 16.1 | 14.4 | 9.1 | 7.6 | |
| Earnings Yield | 3.0% | 6.1% | 6.2% | 6.8% | 5.7% | 7.6% | 5.5% | 4.5% | 3.4% | 6.5% | 5.6% | 5.5% |
Income Statement 17
| Metric | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $223M | $250M | $240M | $214M | $236M | $250M | $214M | $200M | $213M | $228M | $221M | $213M | $248M | $153M | |
| Cost of Revenue | $48M | $59M | $59M | $49M | $50M | $52M | $39M | $39M | $40M | $43M | $42M | $43M | $49M | $35M | |
| Gross Profit | $175M | $191M | $181M | $165M | $186M | $197M | $175M | $161M | $173M | $185M | $179M | $171M | $200M | $118M | |
| SG&A Expense | $82M | $88M | $103M | $86M | $82M | $91M | $73M | $61M | $64M | $64M | $59M | $63M | $67M | $55M | |
| Operating Expenses | $195M | $177M | $191M | $164M | $169M | $181M | $167M | $145M | $155M | $160M | $155M | $153M | $173M | $117M | |
| Operating Income | $-20M | $14M | $-11M | $1M | $17M | $16M | $8M | $16M | $18M | $25M | $24M | $18M | $27M | $984.0K | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $52.0K | · | $43.0K | $31.0K | · | |
| Interest Income | $595.0K | $437.0K | $-2M | $578.0K | $619.0K | $723.0K | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Other Non-op | $501.0K | $1M | $113.0K | $41.0K | $2M | $756.0K | $-390.0K | $-86.0K | $-349.0K | $-186.0K | $-368.0K | $234.0K | $-88.0K | $-852.0K | |
| Pretax Income | $-19M | $15M | $-13M | $2M | $19M | $17M | $10M | $19M | $20M | $27M | $27M | $21M | $29M | $2M | |
| Income Tax | $9M | $9M | $6M | $8M | $8M | $7M | $6M | $8M | $10M | $11M | $10M | $9M | $10M | $5M | |
| Net Income | $-21M | $8M | $-19M | $-7M | $10M | $9M | $4M | $11M | $10M | $17M | $17M | $11M | $18M | $-3M | |
| EPS (Basic) | $-1.16 | $0.41 | $-0.99 | $-0.36 | $0.52 | $0.49 | $0.23 | $0.56 | $0.55 | $0.86 | $0.87 | $0.59 | $0.95 | $-0.03 | |
| EPS (Diluted) | $-1.16 | $0.41 | $-0.99 | $-0.36 | $0.52 | $0.49 | $0.23 | $0.56 | $0.54 | $0.86 | $0.87 | $0.59 | $0.95 | $-0.01 | |
| Shares (Basic) | 18,486,000 | 18,398,000 | -38,105,000 | 18,293,000 | 18,513,000 | 19,049,000 | -38,222,000 | 19,078,000 | 19,073,000 | 19,174,000 | -33,000 | 19,245,000 | 19,283,000 | -40,204,000 | |
| Shares (Diluted) | 18,486,000 | 18,411,000 | -38,130,000 | 18,293,000 | 18,536,000 | 19,085,000 | -38,382,000 | 19,083,000 | 19,159,000 | 19,302,000 | -31,000 | 19,372,000 | 19,328,000 | -40,511,000 | |
| EBITDA | $-12M | $22M | · | $9M | $24M | $24M | · | $16M | $18M | $28M | · | $18M | $30M | · |
Balance Sheet 25
| Metric | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $169M | $163M | $158M | $145M | $151M | $180M | $182M | $365M | $332M | $328M | $330M | $307M | $295M | $288M | |
| Receivables | $3M | $10M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory | $86M | $96M | $103M | $91M | $83M | $74M | $70M | $64M | $62M | $61M | · | $60M | $64M | · | |
| Prepaid Expense | $23M | $25M | $27M | $28M | $27M | $28M | $28M | $22M | $25M | $32M | · | $23M | $36M | · | |
| Other Current Assets | · | · | $5M | · | · | · | $5M | · | · | · | · | · | · | · | |
| Current Assets | $281M | $294M | $288M | $264M | $262M | $281M | $279M | $451M | $419M | $421M | · | $390M | $396M | · | |
| PP&E (Net) | $94M | $95M | $94M | $96M | $97M | $94M | $95M | $98M | $98M | $98M | · | $95M | $97M | · | |
| Accum. Depreciation | · | · | $135M | · | · | · | $130M | · | · | · | · | · | · | · | |
| Goodwill | $109M | $138M | $138M | $144M | $144M | $144M | $144M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | |
| Intangibles | $125M | $129M | $133M | $138M | $143M | $147M | $152M | $29M | $29M | $29M | · | $29M | $32M | · | |
| Other Non-current Assets | $65M | $58M | $62M | $60M | $63M | $61M | $59M | $59M | $51M | $53M | · | $54M | $56M | · | |
| Total Assets | $703M | $739M | $743M | $727M | $735M | $747M | $748M | $671M | $631M | $629M | · | $601M | $606M | · | |
| Accounts Payable | $15M | $16M | $17M | $16M | $18M | $14M | $12M | $7M | $7M | $8M | · | $9M | $11M | · | |
| Accrued Liabilities | · | · | $10M | · | · | · | $14M | · | · | · | · | · | · | · | |
| Current Liabilities | $106M | $117M | $129M | $119M | $122M | $137M | $140M | $115M | $104M | $113M | · | $113M | $130M | · | |
| Capital Leases | · | · | $12M | · | · | · | $10M | · | · | · | · | · | · | · | |
| Deferred Tax | $5M | $5M | $5M | $4M | $5M | $5M | $4M | $5M | $5M | $5M | · | $5M | $6M | · | |
| Other Non-current Liabilities | $22M | $22M | $23M | $22M | $23M | $21M | $18M | $19M | $11M | $12M | · | $13M | $14M | · | |
| Total Liabilities | $132M | $144M | $157M | $145M | $149M | $163M | $162M | · | · | · | · | · | · | · | |
| Common Stock | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | · | $19.0K | $19.0K | · | |
| Retained Earnings | $452M | $473M | $466M | $467M | $474M | $478M | $479M | $474M | $464M | $453M | · | $428M | $410M | · | |
| AOCI | $-14M | $-14M | $-16M | $-19M | $-19M | $-23M | $-23M | $-14M | $-21M | $-19M | · | $-20M | $-11M | · | |
| Stockholders' Equity | $526M | $544M | $533M | $528M | $531M | $530M | $532M | $533M | $512M | $500M | $497M | $470M | $455M | $434M | |
| Liabilities + Equity | $703M | $739M | $743M | $727M | $735M | $747M | $748M | $671M | $631M | $629M | · | $601M | $606M | · | |
| Shares Outstanding | 18,463,000 | 18,457,000 | 18,281,000 | 18,272,000 | 18,262,000 | 18,786,000 | 19,064,000 | 19,056,000 | 19,051,000 | 19,047,000 | 19,130,000 | 19,122,000 | 19,294,000 | 19,206,000 |
Cash Flow 12
| Metric | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $8M | $13M | $8M | $8M | $8M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Stock-based Comp | $3M | $3M | $3M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Other Non-cash | · | · | · | · | · | $-5M | · | · | · | $-6M | · | · | $-12M | · | |
| Operating Cash Flow | $23M | $10M | $-33M | $-2M | $12M | $15M | $6M | $28M | $8M | $18M | $26M | $22M | $13M | $40M | |
| CapEx | $3M | $3M | $6M | $3M | $5M | $3M | $2M | $441.0K | $3M | $3M | $7M | $1M | $2M | $3M | |
| Investing Cash Flow | $-4M | $-3M | $-2M | $-3M | $-4M | $-4M | $-205M | $85.0K | $-2M | $-4M | $-7M | $-1M | $-3M | $-3M | |
| Stock Repurchased | $0 | $0 | $18M | $0 | $15M | $12M | $0 | $-18M | $0 | $9M | $0 | $12M | $0 | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-12M | · | · | · | $-9M | · | · | $0 | · | |
| Financing Cash Flow | $-14M | $-4M | $-27M | $-979.0K | $-39M | $-14M | $23M | $40M | $-1M | $-12M | $658.0K | $-12M | $-3M | $-150.0K | |
| Net Change in Cash | $6M | $4M | $-58M | $-6M | $-28M | $-2M | $-183M | $65M | $4M | $-2M | $23M | $7M | $7M | $41M | |
| Free Cash Flow | · | $7M | · | · | · | $13M | · | · | · | $14M | · | · | $11M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $14M | · | · | $11M | · |
Profitability 8
| Metric | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.3% | 76.2% | · | 77.1% | 78.7% | 79.0% | · | 80.4% | 81.0% | 81.1% | · | 80.1% | 80.5% | · | |
| Operating Margin | -9.0% | 5.5% | · | 0.57% | 7.1% | 6.3% | · | 7.8% | 8.4% | 10.8% | · | 8.2% | 10.8% | · | |
| Net Margin | -9.6% | 3.0% | · | -3.0% | 4.1% | 3.8% | · | 5.3% | 4.9% | 7.3% | · | 5.3% | 7.4% | · | |
| Pretax Margin | -8.5% | 6.2% | · | 0.84% | 8.0% | 6.7% | · | 9.3% | 9.5% | 11.9% | · | 9.6% | 11.5% | · | |
| EBITDA Margin | -5.5% | 8.8% | · | 4.3% | 10.4% | 9.6% | · | 7.8% | 8.4% | 12.2% | · | 8.2% | 12.1% | · | |
| ROA | -3.0% | 1.0% | · | -0.93% | 1.4% | 1.4% | · | 1.7% | 1.7% | 2.7% | · | 2.0% | · | · | |
| ROE | -4.0% | 1.4% | · | -1.2% | 1.8% | 1.8% | · | 2.1% | 2.1% | 3.5% | · | 2.6% | · | · | |
| ROIC | -5.6% | 1.1% | · | -0.86% | 1.8% | 1.6% | · | 1.7% | 1.8% | 3.0% | · | 2.1% | · | · |
Liquidity & Solvency 3
| Metric | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | 2.5 | · | 2.2 | 2.2 | 2.0 | · | 3.9 | 4.0 | 3.7 | · | 3.5 | · | · | |
| Quick Ratio | 1.6 | · | · | 1.2 | 1.2 | 1.3 | · | 3.2 | 3.2 | 2.9 | · | 2.7 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 474.5 | · | 409.5 | 866.0 | · |
Efficiency 3
| Metric | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | · | · | |
| Inventory Turnover | 0.6 | 0.7 | · | 0.6 | 0.7 | 0.8 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | · | · | |
| Receivables Turnover | 133.8 | 51.8 | · | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM) 10
| Metric | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $923M | $949M | · | $899M | $898M | $890M | · | $854M | $892M | $928M | · | $933M | $1.02B | · | |
| Net Income TTM | $-11M | $20M | · | $23M | $40M | $47M | · | $49M | $56M | $64M | · | $62M | $75M | · | |
| Market Cap | $397M | $312M | · | $521M | $568M | $522M | · | $723M | $862M | $924M | · | $1.12B | · | · | |
| P/E | -36.5 | 15.9 | · | 23.6 | 14.8 | 11.3 | · | 14.9 | 15.7 | 14.7 | · | 18.3 | 16.2 | · | |
| P/S | 0.4 | 0.3 | · | 0.6 | 0.6 | 0.6 | · | 0.8 | 1.0 | 1.0 | · | 1.2 | · | · | |
| P/B | 0.8 | 0.6 | · | 1.0 | 1.1 | 1.0 | · | 1.4 | 1.7 | 1.8 | · | 2.4 | · | · | |
| P / Tangible Book | 1.4 | 1.1 | · | 2.1 | 2.3 | 2.2 | · | 1.5 | 1.8 | 2.0 | · | 2.6 | · | · | |
| P / Cash Flow | · | 32.0 | · | · | · | 33.7 | · | · | · | 52.2 | · | · | · | · | |
| P / FCF | · | 43.8 | · | · | · | 41.2 | · | · | · | 63.8 | · | · | · | · | |
| Earnings Yield | -2.7% | 6.3% | · | 4.2% | 6.8% | 8.8% | · | 6.7% | 6.4% | 6.8% | · | 5.5% | 6.2% | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2026-01-03 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2022-01-01 | |
|---|---|---|---|---|---|
| Revenue | $925M | $855M | $921M | $999M | $1.19B |
| Gross Margin % | 78.3% | 81.1% | 80.8% | 80.6% | 81.6% |
| Operating Margin % | 4.0% | 7.8% | 10.1% | 10.8% | 14.3% |
| Net Income | $11M | $42M | $64M | $69M | $117M |
| Diluted EPS | $0.58 | $2.19 | $3.30 | $3.59 | $5.73 |
Balance Sheet
| 2026-01-03 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2022-01-01 | |
|---|---|---|---|---|---|
| Current Ratio | 2.2 | 2.0 | 3.5 | 2.7 | 2.3 |
| Quick Ratio | 1.2 | 1.3 | 2.8 | 2.0 | 1.5 |
Cash Flow
| 2026-01-03 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2022-01-01 | |
|---|---|---|---|---|---|
| Free Cash Flow | $9M | $51M | $56M | $94M | $108M |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 152 filers · $176.6M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 30 (+4 vs prior Q) | 16 (+6 vs prior Q) | 48 (+5 vs prior Q) | 34 (-7 vs prior Q) | +1.1M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| PZENA INVESTMENT MANAGEMENT LLC | $25,739,282 | 1,205,587 | 14.58% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $20,464,402 | 958,520 | 11.59% | Shares |
| Nantahala Capital Management, LLC | $17,295,080 | 810,074 | 9.80% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $16,958,134 | 794,292 | 9.61% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $10,405,350 | 487,370 | 5.89% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $7,758,099 | 363,377 | 4.39% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $5,811,641 | 272,208 | 3.29% | Shares |
| STATE STREET CORP | $5,577,474 | 261,240 | 3.16% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $5,175,448 | 242,342 | 2.93% | Shares |
| AMERICAN CENTURY COMPANIES INC | $3,999,880 | 187,348 | 2.27% | Shares |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3,855,105 | 180,567 | 2.18% | Shares |
| TWO SIGMA INVESTMENTS, LP | $3,533,724 | 165,514 | 2.00% | Shares |
| D. E. Shaw & Co., Inc. | $3,348,427 | 156,835 | 1.90% | Shares |
| Allianz Asset Management GmbH | $3,040,219 | 142,399 | 1.72% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $2,949,567 | 138,153 | 1.67% | Shares |
| ALGERT GLOBAL LLC | $2,813,033 | 131,758 | 1.59% | Shares |
| UBS Group AG | $2,474,166 | 115,886 | 1.40% | Shares |
| BlackRock, Inc. | $2,353,005 | 110,211 | 1.33% | Shares |
| LAZARD ASSET MANAGEMENT LLC | $2,077,590 | 97,311 | 1.18% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,549,540 | 72,578 | 0.88% | Shares |
| Vanguard Global Advisers, LLC | $1,514,569 | 70,940 | 0.86% | Shares |
| Empowered Funds, LLC | $1,499,902 | 70,253 | 0.85% | Shares |
| AMERIPRISE FINANCIAL INC | $1,443,624 | 67,617 | 0.82% | Shares |
| TWO SIGMA ADVISERS, LP | $1,289,691 | 65,700 | 0.73% | Shares |
| GOLDMAN SACHS GROUP INC | $1,121,921 | 52,549 | 0.64% | Shares |
| Quantinno Capital Management LP | $1,072,261 | 50,223 | 0.61% | Shares |
| BANK OF AMERICA CORP /DE/ | $967,539 | 45,318 | 0.55% | Shares |
| ROYCE & ASSOCIATES LP | $884,039 | 41,407 | 0.50% | Shares |
| DEUTSCHE BANK AG\ | $821,975 | 38,500 | 0.47% | Shares |
| Assenagon Asset Management S.A. | $815,848 | 38,213 | 0.46% | Shares |
| BARCLAYS PLC | $769,220 | 36,029 | 0.44% | Shares |
| STRS OHIO | $723,765 | 33,900 | 0.41% | Shares |
| Skopos Labs, Inc. | $673,696 | 38,563 | 0.38% | Shares |
| HSBC HOLDINGS PLC | $672,758 | 31,960 | 0.38% | Shares |
| Bank of New York Mellon Corp | $668,447 | 31,309 | 0.38% | Shares |
| XTX Topco Ltd | $625,320 | 29,289 | 0.35% | Shares |
| MILLENNIUM MANAGEMENT LLC | $570,728 | 26,732 | 0.32% | Shares |
| CITADEL ADVISORS LLC | $569,639 | 26,681 | 0.32% | Shares |
| Verdad Advisers, LP | $556,552 | 26,068 | 0.32% | Shares |
| Sanctuary Advisors, LLC | $497,113 | 23,284 | 0.28% | Shares |
| Man Group plc | $489,854 | 22,944 | 0.28% | Shares |
| State of Tennessee, Department of Treasury | $461,160 | 21,600 | 0.26% | Shares |
| Point72 Asset Management, L.P. | $397,238 | 18,606 | 0.22% | Shares |
| Unison Advisors LLC | $384,300 | 18,000 | 0.22% | Shares |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $384,215 | 17,996 | 0.22% | Shares |
| Numerai GP LLC | $382,080 | 17,896 | 0.22% | Shares |
| KLP KAPITALFORVALTNING AS | $375,760 | 17,600 | 0.21% | Shares |
| Connor, Clark & Lunn Investment Management Ltd. | $366,836 | 17,182 | 0.21% | Shares |
| ALLIANCEBERNSTEIN L.P. | $357,611 | 20,470 | 0.20% | Shares |
| CITADEL ADVISORS LLC | $356,545 | 16,700 | 0.20% | Put option |
| Park Capital Management, LLC / WI | $345,144 | 16,166 | 0.20% | Shares |
| Engineers Gate Manager LP | $337,672 | 15,816 | 0.19% | Shares |
| SEGALL BRYANT & HAMILL, LLC | $318,414 | 14,914 | 0.18% | Shares |
| RHUMBLINE ADVISERS | $309,778 | 14,510 | 0.18% | Shares |
| Vanguard Personalized Indexing Management, LLC | $309,724 | 14,507 | 0.18% | Shares |
| FIRST TRUST ADVISORS LP | $308,998 | 14,473 | 0.18% | Shares |
| Toroso Investments, LLC | $304,756 | 15,525 | 0.17% | Shares |
| EXCHANGE TRADED CONCEPTS, LLC | $300,992 | 14,098 | 0.17% | Shares |
| IEQ CAPITAL, LLC | $300,245 | 14,063 | 0.17% | Shares |
| Y-Intercept (Hong Kong) Ltd | $298,366 | 13,975 | 0.17% | Shares |
| Focus Partners Wealth | $292,794 | 13,714 | 0.17% | Shares |
| CITADEL ADVISORS LLC | $273,280 | 12,800 | 0.15% | Call option |
| BNP PARIBAS FINANCIAL MARKETS | $263,160 | 12,326 | 0.15% | Shares |
| MERCER GLOBAL ADVISORS INC /ADV | $243,881 | 11,423 | 0.14% | Shares |
| State of Wyoming | $242,237 | 11,346 | 0.14% | Shares |
| ANCHYRA PARTNERS LLC | $230,238 | 10,784 | 0.13% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $229,982 | 10,772 | 0.13% | Shares |
| OCCUDO QUANTITATIVE STRATEGIES LP | $226,652 | 10,616 | 0.13% | Shares |
| Mariner, LLC | $219,915 | 10,302 | 0.12% | Shares |
| DGS Capital Management, LLC | $207,876 | 11,899 | 0.12% | Shares |
| Cerity Partners LLC | $141,913 | 6,647 | 0.08% | Shares |
| Magnetar Financial LLC | $138,540 | 6,489 | 0.08% | Shares |
| MetLife Investment Management, LLC | $124,236 | 5,819 | 0.07% | Shares |
| Russell Investments Group, Ltd. | $123,637 | 5,791 | 0.07% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $109,931 | 5,149 | 0.06% | Shares |
| Creative Planning | $107,156 | 5,019 | 0.06% | Shares |
| FMR LLC | $105,661 | 4,949 | 0.06% | Shares |
| SIGNATUREFD, LLC | $101,391 | 4,749 | 0.06% | Shares |
| CWM, LLC | $97,413 | 5,576 | 0.06% | Shares |
| VANGUARD GROUP INC | $96,226 | 4,902 | 0.05% | Shares |
| Invesco Ltd. | $95,072 | 4,453 | 0.05% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $81,045 | 3,796 | 0.05% | Shares |
| Police & Firemen's Retirement System of New Jersey | $73,935 | 3,463 | 0.04% | Shares |
| Parallel Advisors, LLC | $70,818 | 3,317 | 0.04% | Shares |
| Farther Finance Advisors, LLC | $41,873 | 1,964 | 0.02% | Shares |
| Arax Advisory Partners | $40,588 | 1,901 | 0.02% | Shares |
| NATIONAL BANK OF CANADA /FI/ | $40,499 | 1,896 | 0.02% | Shares |
| AlphaQuest LLC | $38,259 | 1,949 | 0.02% | Shares |
| NORTHERN TRUST CORP | $37,533 | 1,758 | 0.02% | Shares |
| OSAIC HOLDINGS, INC. | $34,383 | 1,611 | 0.02% | Shares |
| LOM Asset Management Ltd | $34,160 | 1,600 | 0.02% | Shares |
| Versant Capital Management, Inc | $33,904 | 1,588 | 0.02% | Shares |
| MORGAN STANLEY | $31,363 | 1,469 | 0.02% | Shares |
| Ameritas Investment Partners, Inc. | $23,933 | 1,121 | 0.01% | Shares |
| Tower Research Capital LLC (TRC) | $22,909 | 1,073 | 0.01% | Shares |
| Legal & General Group Plc | $20,966 | 982 | 0.01% | Shares |
| Integrated Wealth Concepts LLC | $18,833 | 882 | 0.01% | Shares |
| CITIGROUP INC | $17,635 | 826 | 0.01% | Shares |
| Global Retirement Partners, LLC | $14,433 | 676 | 0.01% | Shares |
| Allworth Financial LP | $14,027 | 657 | 0.01% | Shares |
Company insiders 38 insiders · 20 officers · 13 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jim Brown | CEO & PRESIDENT | July 24, 2025 M | 16,934 | 0 | 0 | $0 |
| Doug G Iiekking | CHIEF FINANCIAL OFFICER | May 27, 2026 S | 0 | 0 | 1 | $-100,500 |
| Jeffrey Yates | Chief Financial Officer | Oct. 28, 2010 M | 0 | 0 | 0 | $0 |
| Deborah Woo | President of Asia | Sept. 8, 2016 M | 1,479 | 0 | 0 | $0 |
| Fred W Cooper | President and COO | Oct. 28, 2010 M | 0 | 0 | 0 | $0 |
| Walter Noot | CHIEF OPERATING OFFICER | Feb. 19, 2026 A | 0 | 0 | 0 | $0 |
| Roy Truett | Chief Operating Officer | July 27, 2012 M | 0 | 0 | 0 | $0 |
| Kathryn Michelle Armstrong | CHIEF SCIENTIFIC OFFICER | July 25, 2026 M | 3,471 | 0 | 0 | $0 |
| Peter Benedict | CHIEF INFORMATION OFFICER | July 25, 2026 M | 422 | 0 | 0 | $0 |
| Brent Neidig | CHIEF COMMERCIAL OFFICER | June 16, 2026 S | 0 | 0 | 3 | $-147,749 |
| Paul A. Jones | CHIEF PEOPLE OFFICER | June 8, 2026 S | 0 | 0 | 1 | $-102,878 |
| David Mulham Mulham | CHIEF SALES OFFICER | July 30, 2025 S | 9,260 | 0 | 0 | $0 |
| Joshua Foukas | CHIEF LEGAL OFFICER | March 12, 2025 S | 0 | 0 | 0 | $0 |
| Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | May 2, 2024 S | 0 | 0 | 0 | $0 |
| Robert A Sinnott | CHIEF SCIENTIFIC OFFICER | March 5, 2024 S | 0 | 0 | 0 | $0 |
| James Bramble | Chief Legal Officer and Sec | Feb. 5, 2018 A | 2,076 | 0 | 0 | $0 |
| Dave Wentz | Co-C.E.O. | Aug. 16, 2016 M | 384,883 | 0 | 0 | $0 |
| Rick Stambaugh | Chief Information Officer | Dec. 17, 2015 M | 0 | 0 | 0 | $0 |
| Mark H Wilson | E.V.P. of Sales | Oct. 28, 2010 M | 5,000 | 0 | 0 | $0 |
| Bradford Richardson | E.V.P. of Asia Pacific | Feb. 25, 2008 S | 0 | 0 | 0 | $0 |
| Xia Ding | Director | July 23, 2026 M | 8,278 | 0 | 0 | $0 |
| John Turman Fleming | Director | July 23, 2026 M | 5,862 | 0 | 1 | $-43,928 |
| Peggie Pelosi | Director | July 23, 2026 M | 6,061 | 0 | 0 | $0 |
| Scott J Nixon | Director | July 23, 2026 M | 11,445 | 0 | 0 | $0 |
| Frederic J Winssinger | Director | July 23, 2026 M | 9,733 | 0 | 0 | $0 |
| Timothy E Wood | Director | July 23, 2026 M | 11,837 | 0 | 0 | $0 |
| Gilbert A Fuller | Director | July 23, 2026 M | 1,632 | 0 | 3 | $-60,414 |
| Robert Auciaux | Director | Feb. 9, 2022 M | 436 | 0 | 0 | $0 |
| Feng Peng | Director | April 28, 2021 M | 755 | 0 | 0 | $0 |
| Myron W. Wentz | Director | Feb. 4, 2019 S | 9,865,614 | 0 | 0 | $0 |
| Jerry G Mcclain | Director | March 4, 2016 M | 0 | 0 | 0 | $0 |
| Ronald S Poelman | Director | Feb. 8, 2016 A | 0 | 0 | 0 | $0 |
| Denis E Waitley | Director | Nov. 3, 2006 M | 0 | 0 | 0 | $0 |
| Gull Global Limited | 10% owner | Feb. 4, 2019 S | 9,865,614 | 0 | 0 | $0 |
| GULL HOLDINGS LTD | 10% owner | April 1, 2015 J | 6,491,110 | 0 | 0 | $0 |
| Kevin Guest | — | Feb. 27, 2026 M | 45,381 | 0 | 0 | $0 |
| Donald R. Williams | — | May 1, 2017 A | — | 0 | 0 | $0 |
| Doug Braun | — | Dec. 16, 2015 M | 0 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 3 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Gull Global Limited, Myron W. Wentz ×11 filings | March 30, 2026 | 40.10% | Amendment | M&A / sale | SEC |
| Gull Holdings, Ltd., Myron W. Wentz, David A. Wentz, Jacquelyn R. Wentz, Bryan Wentz, Annette Wentz, Paul & Jane Meyer Family Foundation, Paul James Meyer, Alice Jane Meyer, Centre Island Properties, Ltd., Waco Boys Club Foundation, Inc., L-K Marketing Group, LLC, Beagle Irrevocable Asset Trust | May 23, 2008 | — | Initial filing | — | SEC |
| Paul & Jane Meyer Family Foundation | May 20, 2008 | — | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 38 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| DEEP · ETF Series Solutions | 0.95% | 13,646 NS | May 31, 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0.25% | 13,206 NS | May 31, 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.11% | 45,046 SH | Aug. 8, 2026 | Daily |
| EBIT · Harbor ETF Trust | 0.06% | 387 NS | April 30, 2026 | N-PORT |
| IWC · iShares Trust | 0.04% | 38,121 SH | Aug. 8, 2026 | Daily |
| FNDA · SCHWAB STRATEGIC TRUST | 0.03% | 169,505 NS | May 31, 2026 | N-PORT |
| VDC · VANGUARD WORLD FUND | 0.03% | 128,565 SH | Aug. 8, 2026 | Daily |
| GSSC · Goldman Sachs ETF Trust | 0.03% | 15,259 NS | May 31, 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.02% | 87,994 NS | April 30, 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 9,639 SH | Aug. 8, 2026 | Daily |
| DFAT · Dimensional ETF Trust | 0.01% | 97,080 NS | April 30, 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 24,189 SH | Aug. 8, 2026 | Daily |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.01% | 18,642 NS | May 31, 2026 | N-PORT |
| AVUV · AMERICAN CENTURY ETF TRUST | 0.01% | 159,569 NS | May 31, 2026 | N-PORT |
| IWN · iShares Trust | 0.01% | 101,080 SH | Aug. 8, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 64,278 SH | Aug. 8, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.01% | 60,807 NS | April 30, 2026 | N-PORT |
| SMLF · iShares Trust | 0.01% | 22,748 SH | Aug. 8, 2026 | Daily |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.01% | 1,195 SH | Aug. 8, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 4,685 NS | April 30, 2026 | N-PORT |
| IWM · iShares Trust | 0.01% | 283,211 SH | Aug. 8, 2026 | Daily |
| ITWO · ProShares Trust | 0.01% | 508 NS | May 31, 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.00% | 51,773 NS | May 31, 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0.00% | 2,158 NS | May 31, 2026 | N-PORT |
| UWM · ProShares Trust | 0.00% | 397 NS | May 31, 2026 | N-PORT |
| URTY · ProShares Trust | 0.00% | 406 NS | May 31, 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0.00% | 247 NS | May 31, 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 388 NS | May 31, 2026 | N-PORT |
| HDG · ProShares Trust | 0.00% | 10 NS | May 31, 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 5,468 NS | May 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 19,278 NS | April 30, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 22,758 SH | Aug. 8, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 3,680 SH | Aug. 8, 2026 | Daily |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 6,500 NS | May 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 1,784 NS | April 30, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 124,681 SH | Aug. 8, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 350,035 SH | Aug. 8, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 790 SH | Aug. 8, 2026 | Daily |